Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis

Area of Science:

• Pulmonology
• Cell Biology
• Immunology

Background:

• Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease marked by fibroblast proliferation and myofibroblast differentiation.
• The role of neutrophils and their enzymes, like neutrophil elastase (NE), in IPF pathogenesis is not fully understood, despite correlations between neutrophil accumulation and poor outcomes.

Purpose of the Study:

• To investigate the role of neutrophil elastase (NE) in the progression of lung fibrosis.
• To determine if NE directly influences fibroblast proliferation and myofibroblast differentiation.
• To evaluate the therapeutic potential of NE inhibition in lung fibrosis.

Main Methods:

• Comparison of asbestos-induced lung fibrosis in wild-type and NE-deficient (NE(-/-)) mice.
• In vitro assays assessing NE's direct effects on lung fibroblast proliferation, myofibroblast differentiation (αSMA induction), and collagen gel contractility.
• Treatment of asbestos-exposed mice with ONO-5046, a synthetic NE antagonist, to measure hydroxyproline content.

Main Results:

• NE(-/-) mice exhibited protection against asbestos-induced lung fibrosis, with reduced fibroblast and myofibroblast content.
• NE directly stimulated lung fibroblast proliferation and myofibroblast differentiation in vitro, independent of TGF-β signaling.
• Administration of a NE antagonist (ONO-5046) significantly reduced lung hydroxyproline content in mice.

Conclusions:

• Neutrophils and their enzyme NE play a critical role in the development and progression of lung fibrosis.
• NE directly promotes key fibrotic processes, including fibroblast proliferation and myofibroblast differentiation.
• Targeting NE through inhibitory approaches represents a promising novel therapeutic strategy for patients suffering from lung fibrosis.